Mesenchymal Stem Cell-Induced Doxorubicin Resistance in Triple Negative Breast Cancer

Triple negative breast cancer (TNBC) is an aggressive histological subtype with limited treatment options and a worse clinical outcome compared with other breast cancer subtypes. Doxorubicin is considered to be one of the most effective agents in the treatment of TNBC. Unfortunately, resistance to t...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Dar-Ren, Lu, Dah-Yuu, Lin, Hui-Yi, Yeh, Wei-Lan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4124237/
https://www.ncbi.nlm.nih.gov/pubmed/25140317
http://dx.doi.org/10.1155/2014/532161

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4124237/
https://www.ncbi.nlm.nih.gov/pubmed/25140317
http://dx.doi.org/10.1155/2014/532161

Ejemplares similares